Experiments were conducted to determine whether human lymphokine-activated killer ( 
Tt
oxoplasma gondii is an obligate intracellular protozoan hat infects humans throughout the world. Although T. gondii is a relatively uncommon cause of disease in immunocompetent individuals, those with a deficiency in cellmediated immunity (i~., AIDS patients, those on high dosage of cytotoxic drugs or corticosteroids, newborns, and fetuses) may develop severe disease because of this parasite (1, 2) .
Cell-mediated immunity plays a major role in protection against T. gondii (3) (4) (5) . Although both CD4 + and CD8 + T lymphocytes are important in this resistance, CD8 + T lymphocytes appear to be the paramount subset in the protective response (4, 5) . CD8 + T lymphocytes may provide protection through lysis of cells infected with the parasite (6) (7) (8) and/or secretion of cytokines (5) .
The role in T. gondii infection of cells that do not require prior sensitization with antigen to respond remains controversial. Whereas some investigators have reported that NK cells are cytotoxic against extracellular tachyzoites of T. gondii (9, 10) , others have been unable to reproduce this observation (11, 12) . Our previous observation that administration of IL-2 to mice resulted in significant survival of these animals after an ordinarily lethal challenge with T. gondii (13) raised the possibility that lymphokine-activated killer (LAK) 1 cells confer protection against this parasite. LAK cells are effector cells that upon culture with Ib2 become cytotoxic for NK-resistant targets, including fresh autologous and allogeneic tumor cells and tumor cell lines (14, 15) . LAK cells have been proven effective as adoptive immunotherapy in animal models of metastasic tumors and viral infection, as well as in patients with some forms of cancer (16) (17) (18) (19) (20) . We considered it interesting to determine whether human LAK cells have cytotoxic activity against cells infected with T. gondii. In addition, we studied the activity of LAK cells termed adherent LAK (A-LAK) cells, which have a high cytotoxic activity against tumor cells (21) (22) (23) (24) and superior in vivo antimetastatic activity compared to standard (unseparated) LAK (S-LAK) cells (25) .
Materials and Methods
Preparation of PBL. PBMC were obtained after signed consent from normal volunteers who were seronegative for T. gondii antibody in the agglutination test and Sabin-Feldman dye test (DT) (26, 27) . PBMC were isolated from heparinized venous blood by centrifugation on Ficoll-Hypaque gradients (Pharmacia LKB Biotechnology Inc., Piscataway, NJ). Cells were collected from the gradient interphase and washed three times with RPMI 1640 medium (Gibco Laboratories, Grand Island, NY). Cells were then resuspended at a concentration of 20 x 10 + cells/ml in complete medium (CM) consisting of RPMI 1640 supplemented with 2 mM t-glutamine, 5 x 10 -s M 2-ME, 100 U/ml penicillin, 100 #g/ml streptomycin, and 10% heat-inactivated, DT-negative pooled human AB + serum (Irvine Scientific, Santa Aria, CA), loaded onto a prewashed nylon wool column (Polysciences, Inc., Warrington, PA), and eluted from the column after a 1-h incubation at 37~ 5% CO2. Removal of monocytes and B cells was confirmed by FACS | analysis (Becton Dickinson & Co., San Jose, CA).
Isolation of NK and T Cells.
Purification was performed following the methodology previously described (28) . Briefly, nylon wool nonadherent (NWNA) cells were incubated for 30 min on ice with either anti-CO3 mAb (Dako Corp., Carpinteria, CA) or anti-CO56 mAb (Becton Dickinson & Co.). After two washes, magnetic beads coated with goat anti-mouse IgG (Advanced Magnetics, Inc., Cambridge, MA) were added and incubated on ice for 30 rain with frequent mixing. R_osetting cells were removed with a magnet (Dynal, Inc., Great Neck, NY). Addition of magnetic beads was repeated once to ensure adequacy of purification. This procedure resulted in populations purified for CO3-CD16 + CD56 + NK cells (>96% by FACS | analysis) and CO3 § CD16-CD56-T cells (>98% by FACS | analysis).
Preparation of LAK Cells. NWNA cells were cultured at 2 x 106 cells/ml in CM supplemented with 1,000 U/ml of human rib2 (generous gift from Chiron Corporation, Emeryville, CA) in a tissue culture flask (Coming Glass Works, Coming, NY) positioned on its flat side. A-LAK cells were obtained following the protocol of Melder et al. (22) . After 24 h incubation at 37~ 5% CO2, nonadherent cells were removed and adherent cells washed five times with warm R.PMI. Fresh CM supplemented with rlL-2 plus 50% (vol/vol) conditioned medium (supernatant obtained after centrifugation of nonadherent cells) was added to adherent cells. Cell concentration was kept below 2 x 106 cells/ml by adding fresh medium with rlL-2. In flasks containing standard (unseparated) LAK (S-LAK) cells, nonadherent cells were never removed. In experiments in which both types of cell populations were compared, cells were cultured for 8-12 d and fresh rib2 was added every 5 d. Before use in cytotoxicity assays, A-LAK cells as well as S-LAK cells were incubated with cold 5 mM EDTA in PBS for 10 rain to detach adherent cells, and then washed three times. In some experiments, purified NK and T cells were incubated with 1,000 U/ml rib2 for 7 d and then used as effector cells in cytotoxicity assays.
Complement-mediated Depletion of Lymphocyte Subpopulations.
S-LAK cells were incubated for 1 h at 4~ with optimal doses of either anti-CD5 (pan T) mAb (Becton Dickinson & Co.) or anti-CD56 mAb (Coulter Cytometry, Hialeah, FL). This was followed by incubation with a 1:8 dilution of baby rabbit complement (Cedarlane Laboratories Ltd., Horuby, Ontario, Canada) for 1 h at 37~ This treatment was repeated once and resulted in >90% depletion of the appropriate lymphocyte subset as demonstrated by cytofluorometric analysis.
Target Cells. Autologous PHA-induced blasts were obtained by incubating PBMC in RPMI 1640 with 10% FCS (HyClone Laboratories, Inc., Logan, UT) and 2 #g/ml of PHA-P (Sigma Chemical Co., St. Louis, MO) for at least 4 d. Tachyzoites of the RH strain of T. gondii were exposed to 1,300 erg of UV light as previously described (6) and then used to infect PHA-induced blasts at a multiplicity of infection of 10 parasites per PHA-induced blast. Tachyzoites that remained extracellular were removed by FicollHypaque density gradient centrifugation (6) . Cytocentrifuge preparations were made from these cell preparations and the percentage of infected cells was assessed by light microscopy (29) . Rates of infection ranged from 60 to 80%. Tumor cell lines K562 (NK susceptible) and Dandi (NK resistant) (American Type Culture Collection, Rockvilh, MD) were maintained in RPMI 1640 with 10% FCS.
Cytotoxicity Assays. This was performed as previously described with minor modifications (6) . Briefly, 5 x 103 target cells labeled with SlCr were added to wells of 96-well U-bottomed plates (Costar Corp., Cambridge, MA) and incubated with different numbers of effector cells for 4 h at 37~ 5% CO2 in ILPMI 1640 with 10% FCS. Supernatants were harvested and radioactivity counted using a gamma counter (model 5500 B Beckman Instruments, Palo Alto, CA). The percent specific SlCr-release was calculated using the following formula: 100 x [(experimental release -spontaneous release)/(maximum release -spontaneous release)]. Percent specific SlCr-release represents the mean from triplicate wells. When cytotoxic activity was expressed in lyric units, lyric unit was defined as the number of effector cells required to lyse 30% of tumor target cells or 30% of the cells infected with T. gondii. Lyric units were calculated using the method of Bryant et al. (30) .
In experiments in which supernatants from LAK cell preparations were tested for cytotoxic activity, 5 x 103 StCr-labeled target cells were resuspended in serial dilutions of the supernatant and incubated for 4 h at 37~ 5% CO2.
Cold Target Inhibition Assay. Different numbers of unlabeled target cells were added in quadruplicate to wells containing 5 x 103 SlCr-labeled target cells before addition of effector cells. E/T ratios were chosen so that percent specific S~Cr-release was located in the linear portion of the cytotoxicity curve. Percent specific SlCr-release was assayed as described above. Morphology. Cytocentrifuge preparations of effector cells were air-dried and fixed in methanol for 5 rain. Cells were then stained with a 10% solution of Giemsa stain for 25 min and examined by light microscopy.
Statistical Analyses. Data were analyzed using Student's t test and Spearman's rank correlation coef~cient.
Results

Cytotoxic Activity of Resting PBL. Resting NWNA cells from five donors displayed minimal cytotoxic activity against
T. gondii-infected cells (Fig. 1 a) . Cytotoxicity against uninfected cells was not observed in any case. NK and T cells were purified from resting NWNA cells and their cytotoxicity tested against T. gondii-infected cells, K562 cells, and Daudi cells. Whereas purified NK cells displayed higher cytotoxic activity against K562 cells than NWNA cell preparations, purified T cells had no lytic activity against these target cells (Fig. 1 b) . In contrast, neither NK nor T cells displayed any significant cytotoxic activity against T. gondii-infected cells (Fig. 1 a) . None of the cell populations were cytotoxic for Daudi cells (data not shown). (Fig. 2 a) . Incubation with rib2 also resulted in increased cytotoxic activity against K562 cells, as well as induction of cytotoxic activity against Daudi cells (Fig. 2 b) . Enhancement of the cytotoxic activity against T. gondii-infected cells and Daudi cells required the presence of rib2 since NWNA cells incubated in CM without rlL,2 did not exhibit significant cytotoxic activity against either of these targets (Fig. 2, a  and b) . Kinetics of induction of LAK activity was studied by incubating NWNA cells with 1,000 U/ml rlL-2 for 4, 7, and 12 d. As can be seen in Fig. 3, a and 
Effect of
Comparison of Cytotoxic Activity of S-LAK and A-LAK Cells. Selection of cells induced to attach to plastic by incubation with rib2 (A-LAK cells) resulted in enrichment for CD3-CD56 § cells and for cells with LGL morphology
T. gondii-infected cells (a) and tumor cells (b shows results obtained with Daudi cells; similar results were observed with K562 cells). Either NWNA cells (D), NK cells (I), or T cells (Q) were incubated with lb2 for 7 d.
Results are representative of those obtained in four separate experiments. A-LAK cells from each of the five donors displayed higher cytotoxic activity against tumor cells than did S-LAK cells (Table 2) . Furthermore, when seven independently obtained A-LAK preparations were analyzed, a significant correlation between cytotoxic activity of A-LAK cells against tumor cells and the percentage of CD3-CD56 + cells in the A-LAK preparations was observed (p <0.05). Preparations with the highest percentage of CD3-CD56 + cells tended to have the highest cytotoxic activity, whereas A-LAK preparations with the lowest percentage of CD3-CD56 + cells usually had the lowest cytotoxic activity (Tables 1 and 2) .
A-LAK cells also displayed higher cytotoxic activity than S-LAK cells against T. gondii-infected cells (Table 2) . However, no correlation between the percentage of CD3-CD56 + cells in A-LAK preparations and cytotoxic activity of these effector cells against T. gondii-infected targets was observed ~ ;>0.5).
Cold Target Inhibition Assays. 
T gondii-infected cells or Daudi cells (data not shown).
The results of cold target inhibition assays were not dependent on the phenotype of the effector cells since similar results were obtained with LAK cell preparations that were either highly homogeneous by FACS | analysis (97% CD3-CD56 +) or not (50% CD3-CD56+).
Discussion
Here we report that induction of LAK activity by incubation of human PBL from seronegative donors with II.,2 results in the induction of significant cytotoxic activity against human cells infected with the obligate intracellular parasite T. gondii.
This effect of rlI~2 may represent a mechanism of defense against this parasite. Of importance in this regard is the observation of Sharma et al. (13) who reported that in vivo administration of rlL-2 resulted in prolonged survival of mice after a lethal challenge with T. gondii. Although the mechanism by which rlL-2 conferred the protection was not fully elucidated, it is possible that it was, at least in part, due to induction of LAK cells.
In Recently, it has become possible to generate highly cytotoxic LAK cells from purified NK cell cultures (21) (22) (23) (24) . Vujanovic et al. (21) noted that incubation with Ib2 resulted in attachment of NK cells to plastic and applied this observation to establish populations of LAK (A-LAK) cells which are highly cytotoxic against tumor cells. It is interesting to note that although generation of A-LAK cell preparations results in enrichment for cells with the CD3-CD56 + phenotype, our studies as well as those from other investigators (22, 39) show that these populations of cells are at times still heterogeneous by FACS| We observed that A-LAK cells had higher cytotoxic activity than S-LAK cells against T. gondii-infected cells and tumor cells although no significant correlation between the percentage of CD3-CD56 + ceils in the A-LAK preparations and cytotoxicity against T. gondii-infected ceils was observed. A-LAK cells not only have a change in their phenotypic composition compared to S-LAK, but they have also been reported to have higher expression of adhesion molecules (40, 41) . It has been proposed that higher expression of these molecules might be associated with superior cytotoxic activity of A-LAK ceils (41) .
In a previous series of studies on LAK cells from our laboratory, Dannemann et al. (12) reported that human LAK ceils displayed weak cytotoxidty against extracellular tachyzoites of T gondii and that this activity was enhanced by prior incubation of the parasite with serum containing anti-T, gondii antibodies. Cytotoxicity of LAK cells against isolated T. gondii cysts could not be demonstrated (12) . Since T. gondii is predominantly situated intracellularly, the significance of cytotoxic activity against extracellular tachyzoites remains unclear, although it may play a role when parasites are released from infected cells.
Other investigators have reported cytotoxic activity of LAK cells against nonviral intracellular pathogens such as Rkkettsia prowazekii, Rickettsia typhi, L. pneuraophila, M. aviuraintracellulare, and Leishmania major (35, 36, (42) (43) . However, The nature of the site(s) that LAK ceUs recognize on target cells remains undefined. Our results may be analogous to the observation of Grimm et al. (45) who reported that LAK cells recognize cells with "altered seW'. These authors demonstrated that whereas normal human PBL were not susceptible to lysis by LAK cells, TNP-modified PBL were lysed. The results of our cold target inhibition experiments suggest that LAK cells are heterogeneous in their capacity to recognize and lyse different target cells. Our results suggest that there is a subpopulation of LAK cells that recognizes both types of target ceils (T. gondii-infected and tumor cells), whereas other subsets preferentially or exclusively recognize only one of these targets. Similar evidence that suggests that LAK cells display patterns of preferential target ceU lysis was reported by Frodich et al. (34) . Furthermore, heterogeneity in the mechanisms of recognition of target ceUs has also been suggested by others (46) .
Wisseman et al. (47) reported that soluble factors produced by human leukocytes stimulated with either mitogen or R. prowazekii antigen (in the case of immune leukocytes) are cytolytic against cells infected with this intracellular pathogen but not against uninfected cells. The results of our experi-ments performed with supernatants from LAK cell preparations suggest that soluble cytotoxic factors alone do not mediate to a significant extent the cytotoxic activity of LAK cells in short term cytotoxicity assays. However, we cannot rule out the role of cytotoxic molecules secreted by LAK cells after these cells contact T. gondii-infected cells.
The cytotoxic activity of LAK cells against T. gondii-infected cells may prove to be a mechanism by which LAK cells protect against infection with this parasite. Destruction of infected cells would not only deprive the parasites of their required intracelhlar habitat, but also would expose them to activated phagocytic cells and/or to anti-T, gondii antibodies resulting in the destruction of these organisms (27, 48) . Cytokines produced by LAK calls (39) may also result in protection through induction of kiUing or inhibition of the intracellular multiplication of the parasites.
Current antimicrobial regimens for the treatment of toxoplasmosis, although effective, result in a significant incidence of side effects that frequently require their discontinuation in immunocompromised hosts (49) . The development of new effective alternative therapeutic modalities is therefore critical. Immunotherapy using adoptive transfer of LAK cells, usually in conjunction with IL-2, has been proven effective in animal models of metastatic tumors and viral infection and in patients with some forms of cancer (16) (17) (18) (19) (20) . Furthermore, adoptive transfer experiments performed in animals have demonstrated that, when compared to S-LAK cells, A-LAK cells have a superior antimetastatic effect and result in prolonged survival of the animals (25) . Our results in vitro suggest that administration of LAK cells might prove of therapeutic use in immunocompromised patients with toxoplasmosis.
We are grateful to Dr. John Bryant for invaluable assistance and to Chiton Corporation for providing us with rlL-2.
This work was supported in part by grants AI-04717 and AI-30230 from the National Institutes of Health, and by a MacArthur Foundation grant in molecular parasitology. C. Subauste is the recipient of a fellowship grant from the University of California Universitywide AIDS Research Program and a grant from the Center for AIDS Research, Stanford University.
